JP2017531039A5 - - Google Patents

Download PDF

Info

Publication number
JP2017531039A5
JP2017531039A5 JP2017538467A JP2017538467A JP2017531039A5 JP 2017531039 A5 JP2017531039 A5 JP 2017531039A5 JP 2017538467 A JP2017538467 A JP 2017538467A JP 2017538467 A JP2017538467 A JP 2017538467A JP 2017531039 A5 JP2017531039 A5 JP 2017531039A5
Authority
JP
Japan
Prior art keywords
dihydro
thieno
azaspiro
oxa
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017538467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017531039A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2015/052945 external-priority patent/WO2016055792A1/en
Publication of JP2017531039A publication Critical patent/JP2017531039A/ja
Publication of JP2017531039A5 publication Critical patent/JP2017531039A5/ja
Withdrawn legal-status Critical Current

Links

JP2017538467A 2014-10-10 2015-10-08 新規5,6−ジヒドロ−4H−ベンゾ[b]チエノ−[2,3−d]アゼピン誘導体 Withdrawn JP2017531039A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188494.0 2014-10-10
EP14188494 2014-10-10
PCT/GB2015/052945 WO2016055792A1 (en) 2014-10-10 2015-10-08 Novel 5,6-dihydro-4h-benzo[b]thieno-[2,3-d]azepine derivatives

Publications (2)

Publication Number Publication Date
JP2017531039A JP2017531039A (ja) 2017-10-19
JP2017531039A5 true JP2017531039A5 (cg-RX-API-DMAC7.html) 2018-11-22

Family

ID=51842340

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017538466A Active JP6675407B2 (ja) 2014-10-10 2015-10-08 新規5,6−ジヒドロ−4H−ベンゾ[b]チエノ−[2,3−d]アゼピン誘導体
JP2017538467A Withdrawn JP2017531039A (ja) 2014-10-10 2015-10-08 新規5,6−ジヒドロ−4H−ベンゾ[b]チエノ−[2,3−d]アゼピン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017538466A Active JP6675407B2 (ja) 2014-10-10 2015-10-08 新規5,6−ジヒドロ−4H−ベンゾ[b]チエノ−[2,3−d]アゼピン誘導体

Country Status (13)

Country Link
US (6) US9732098B2 (cg-RX-API-DMAC7.html)
EP (2) EP3204388B1 (cg-RX-API-DMAC7.html)
JP (2) JP6675407B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170058921A (cg-RX-API-DMAC7.html)
CN (1) CN106852144B (cg-RX-API-DMAC7.html)
AU (1) AU2015329789B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017005104B1 (cg-RX-API-DMAC7.html)
CA (1) CA2957868C (cg-RX-API-DMAC7.html)
EA (1) EA201790796A8 (cg-RX-API-DMAC7.html)
IL (1) IL250823A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017004652A (cg-RX-API-DMAC7.html)
SG (1) SG11201701184WA (cg-RX-API-DMAC7.html)
WO (2) WO2016055792A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201701184WA (en) * 2014-10-10 2017-03-30 Pulmocide Ltd Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
US10160772B2 (en) 2014-12-18 2018-12-25 Pulmocide Limited 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
MX381798B (es) 2015-07-22 2025-03-13 Enanta Pharm Inc Derivados de benzodiazepina como inhibidores de rsv
EP3402799B1 (en) 2016-01-15 2022-05-04 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
MY197217A (en) * 2016-02-03 2023-06-01 Janssen Sciences Ireland Uc Combination products for the treatment of rsv
WO2017175000A1 (en) * 2016-04-08 2017-10-12 Pulmocide Limited Compounds
US10398706B2 (en) 2017-01-06 2019-09-03 Enanta Pharmaceuticals, Inc. Heteroaryldiazepine derivatives as RSV inhibitors
CN110809472B (zh) 2017-02-16 2023-05-23 英安塔制药有限公司 用于制备苯二氮䓬衍生物的方法
US10752598B2 (en) 2017-06-07 2020-08-25 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as RSV inhibitors
WO2019006295A1 (en) * 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019006291A1 (en) * 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
US10881666B2 (en) 2017-09-29 2021-01-05 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as RSV inhibitors
JP7228588B2 (ja) 2017-11-13 2023-02-24 エナンタ ファーマシューティカルズ インコーポレイテッド ベンゾジアゼピン-2-オンおよびベンゾアゼピン-2-オン誘導体の分割方法
US10647711B2 (en) 2017-11-13 2020-05-12 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as RSV inhibitors
WO2019199908A1 (en) * 2018-04-11 2019-10-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
BR112021018335A2 (pt) 2019-03-18 2021-11-23 Enanta Pharm Inc Derivados de benzodiazepina como inibidores de rsv
WO2020210246A1 (en) * 2019-04-09 2020-10-15 Enanta Pharmaceuticals, Inc, Heterocyclic compounds as rsv inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
TWI864048B (zh) 2019-10-04 2024-12-01 美商安塔製藥公司 抗病毒雜環化合物、其醫藥組成物及其用途
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2022010882A1 (en) * 2020-07-07 2022-01-13 Enanta Pharmaceuticals, Inc, Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
WO2022086840A1 (en) 2020-10-19 2022-04-28 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
WO2022182861A1 (en) 2021-02-26 2022-09-01 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
AR129003A1 (es) 2022-04-07 2024-07-03 Enanta Pharm Inc Compuestos heterocíclicos antivirales
WO2023211997A1 (en) 2022-04-27 2023-11-02 Enanta Pharmaceuticals, Inc. Antiviral compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693635A (en) 1993-07-29 1997-12-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
CN1183113C (zh) 1999-04-28 2005-01-05 阿文蒂斯药物德国有限公司 作为ppar受体配体的三芳基酸衍生物
JP2011509261A (ja) * 2008-01-07 2011-03-24 シンタ ファーマシューティカルズ コーポレーション 炎症および免疫関連用途向けの化合物
WO2011005842A1 (en) * 2009-07-09 2011-01-13 Gilead Sciences, Inc. Anti-rsv compounds
PT2488486T (pt) 2009-10-13 2019-11-05 Ligand Pharm Inc Compostos de moléculas pequenas de mimética de fator de crescimento hematopoiético e utilizações dos mesmos
ES2823350T3 (es) 2010-07-29 2021-05-06 Rigel Pharmaceuticals Inc Compuestos heterocíclicos que activan AMPK y métodos de uso de los mismos
US9464065B2 (en) 2011-03-24 2016-10-11 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
CA2957017A1 (en) 2014-08-05 2016-02-11 Alios Biopharma, Inc. Combination therapy for treating a paramyxovirus
SG11201701184WA (en) * 2014-10-10 2017-03-30 Pulmocide Ltd Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
EP3402799B1 (en) 2016-01-15 2022-05-04 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
MY197217A (en) 2016-02-03 2023-06-01 Janssen Sciences Ireland Uc Combination products for the treatment of rsv
WO2019006291A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
WO2019006295A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS

Similar Documents

Publication Publication Date Title
JP2017531039A5 (cg-RX-API-DMAC7.html)
JP5911638B2 (ja) ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用
AU2018254577B2 (en) Combination therapies with EHMT2 inhibitors
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
AU2011367809B2 (en) Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
ES2620612T3 (es) Derivados de sulfóxidos y sulfonas de piridinilo y pirimidinilo
JP2009529047A5 (cg-RX-API-DMAC7.html)
AU2013345107B2 (en) Heteroaromatic compounds as PI3 kinase modulators and methods of use
CA2954488C (en) Pyridone derivative having tetrahydropyranylmethyl group
JP2020514267A5 (cg-RX-API-DMAC7.html)
HRP20191268T1 (hr) Derivati tieno[2,3-c]pirol-4-ona kao inhibitori erk
KR20140062120A (ko) 키나아제 저해제로서의 벤조니트릴 유도체
JP2013536869A (ja) Namptの阻害のための新規な化合物及び組成物
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
US9364482B2 (en) Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
AU2021370660A1 (en) Heterocyclic spiro compounds and methods of use
JP2016540803A5 (cg-RX-API-DMAC7.html)
JP2016517877A5 (cg-RX-API-DMAC7.html)
KR20250081951A (ko) 금속 채널 활성화제를 포함하는 병용 요법
US20160108049A1 (en) Novel Phthalazinone-Pyrrolopyrimidinecarboxamide Derivatives
RU2014127984A (ru) Хинолиновые производные как ингибиторы фермента pde10a
CA3005921C (en) Substituted-(pyrrolo[2,3-b]pyridin-3-yl)-pyrimidin derivatives and use thereof as inhibitors of influenza virus replication
WO2024022481A1 (zh) 苯基取代的二氢萘啶类化合物及其制备与用途
HK40023961A (en) Novel benzoimidazoles as selective inhibitors of indoleamine 2, 3-dioxygenases
NZ739951A (en) Colony stimulating factor-1 receptor (csf-1r) inhibitors